John Nuss

John Nuss is a declared insider of Ventyx Biosciences, Inc., with filings sourced from SEC (Form 4). Between 5 December 2022 and 4 March 2026, the trades on record add up to 22 filings.

On the market, this insider has only sold: 7 sales, €2.9M in total. Outside the open market, there are 14 option exercises.

The record was last updated on 4 March 2026 with a transaction in Ventyx Biosciences, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.